Repaglinide (Repide (0.5 mg)) is a meglitinide antidiabetic, prescribed for type 2 (non-insulin-dependent) diabetes. It decreases the amount of glucose by stimulating the pancreas to release insulin.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results